Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiv K Gupta

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
The American Journal of Pathology|September 1, 2009
Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endotheliumRachel B Issaka, Saji Oommen, Shiv K Gupta, et al.
Frontiers in Oncology|March 16, 2019
Current Murine Models and New Developments in H3K27M Diffuse Midline GliomasJohn P Welby, Tatiana Kaptzan, Anton Wohl, et al.
Frontiers in Oncology|February 7, 2019
PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular HeterogeneityShiv K Gupta, Emily J Smith, Ann C Mladek, et al.
Journal of Hematology & Oncology|July 11, 2019
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitorsWeiping Li, Shiv K Gupta, Weiguo Han, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 10, 2021
Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain TumorMinjee Kim, Shiv K Gupta, Wenjuan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2014
Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenograftsShiv K Gupta, Ann C Mladek, Brett L Carlson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2021
Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of GlioblastomaSurabhi Talele, Wenjuan Zhang, Danielle M Burgenske, et al.
Cancer Research|October 30, 2016
DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma MultiformeZachary D Nagel, Gaspar J Kitange, Shiv K Gupta, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 6, 2013
Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinasesMahefatiana Andrianifahanana, Mark C Wilkes, Shiv K Gupta, et al.
Nature Communications|June 21, 2024
ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastomaDaniel J Laverty, Shiv K Gupta, Gary A Bradshaw, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|September 1, 2009
Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endotheliumRachel B Issaka, Saji Oommen, Shiv K Gupta, et al.
Frontiers in Oncology|March 16, 2019
Current Murine Models and New Developments in H3K27M Diffuse Midline GliomasJohn P Welby, Tatiana Kaptzan, Anton Wohl, et al.
Frontiers in Oncology|February 7, 2019
PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular HeterogeneityShiv K Gupta, Emily J Smith, Ann C Mladek, et al.
Journal of Hematology & Oncology|July 11, 2019
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitorsWeiping Li, Shiv K Gupta, Weiguo Han, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 10, 2021
Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain TumorMinjee Kim, Shiv K Gupta, Wenjuan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2014
Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenograftsShiv K Gupta, Ann C Mladek, Brett L Carlson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2021
Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of GlioblastomaSurabhi Talele, Wenjuan Zhang, Danielle M Burgenske, et al.
Cancer Research|October 30, 2016
DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma MultiformeZachary D Nagel, Gaspar J Kitange, Shiv K Gupta, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 6, 2013
Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinasesMahefatiana Andrianifahanana, Mark C Wilkes, Shiv K Gupta, et al.
Nature Communications|June 21, 2024
ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastomaDaniel J Laverty, Shiv K Gupta, Gary A Bradshaw, et al.
Pageof 4